Phase III Study of
PET/CT
decision making
prostate-specific antigen
prostatic neoplasms
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
30
07
2022
revised:
27
10
2022
medline:
5
4
2023
pubmed:
24
11
2022
entrez:
23
11
2022
Statut:
ppublish
Résumé
The objective of this study was to compare
Identifiants
pubmed: 36418170
pii: jnumed.122.264743
doi: 10.2967/jnumed.122.264743
pmc: PMC10071780
doi:
Substances chimiques
PSMA-1007
0
fluorocholine
6029HGL0QP
Gallium Radioisotopes
0
fluoromethylcholine
0
Radiopharmaceuticals
0
Banques de données
ClinicalTrials.gov
['NCT04102553']
Types de publication
Randomized Controlled Trial
Multicenter Study
Clinical Trial, Phase III
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
579-585Informations de copyright
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.
Références
J Nucl Med. 2016 Oct;57(Suppl 3):43S-48S
pubmed: 27694171
Eur Urol. 2020 Apr;77(4):403-417
pubmed: 30773328
J Nucl Med. 2015 Aug;56(8):1185-90
pubmed: 26112024
Am J Nucl Med Mol Imaging. 2019 Apr 15;9(2):127-139
pubmed: 31139496
Clin Nucl Med. 2013 Jan;38(1):e26-32
pubmed: 23242060
Arch Intern Med. 2010 Aug 9;170(15):1390-5
pubmed: 20696967
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4483-4494
pubmed: 34120201
J Urol. 2021 Feb;205(2):356-369
pubmed: 32935652
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):678-688
pubmed: 27889802
Eur Urol. 2018 Aug;74(2):179-190
pubmed: 29678358
Eur J Nucl Med Mol Imaging. 2022 Jun;49(7):2436-2444
pubmed: 35067735
Lancet Oncol. 2018 Oct;19(10):e534-e545
pubmed: 30303127
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2935-2950
pubmed: 33416958
J Nucl Med. 2017 Mar;58(3):425-431
pubmed: 27789722
J Nucl Med. 2021 Feb;62(2):208-213
pubmed: 32817141
PLoS One. 2018 Feb 9;13(2):e0191487
pubmed: 29425221
J Nucl Med. 2019 Mar;60(3):362-368
pubmed: 30042163
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):936-43
pubmed: 22415598
Eur J Cancer. 2021 Nov;157:308-347
pubmed: 34560371